Hilo
Cuffless, automated blood pressure monitoring
- 21-100 employees
- Healthcare
- B2C
- B2B
- Manufacturing
- Automation
- MedTech
- Neuchâtel, NE
Jump to section
Company mission
To transform data into programs and services that will help people live their lives free from hypertension.
Our take
Revolutionising blood pressure monitoring is EU-based MedTech company Hilo (formerly Aktiia). It has developed an innovative cuffless monitor in the form of a wearable bracelet that tracks the wearer’s blood pressure 24/7 and records the data in its easily accessible app.
The company has conducted extensive research, boasting over 120 peer-reviewed publications and around 3 dozen patents. Its approach is to truly change the way patients and physicians understand cardiovascular health, making it easier and more effective to monitor and control blood pressure.
Not only is the company well-backed by research, but it is also well-funded by some of the top investors in Europe and the US - having raised over $100 million to date. It has stated the ambitious goal to help 100 million people control their blood pressure by 2032, with its sights set on making a real impact on public health.
Freddie
Company Specialist at Welcome to the Jungle
Benefits
- Flexible & Fully Remote in the US and Europe
Funding (last 2 of 5 rounds)
May 2025
$42m
SERIES B
Feb 2024
$30m
EARLY VC
Total funding: $101m
This company has top investors
Leadership
Josep Solà
(CTO & Founder)After completing their PhD Research at CSEM they moved on to become the Leader of R&D and BD in Cuffless Blood Pressure Monitoring at the company.
Stefan Petzinger
(CEO)Joined the company as a contracted Chief Growth Officer in 2025, becoming CEO/Member of the Board of Directors later that year. Is also Chair of Customer and Product Committee at Hapimag, and an Angel Investor.